Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1977 Jul;36(1):1–6. doi: 10.1038/bjc.1977.147

Monocytes and macrophages in malignant melanoma. I. Peripheral blood macrophage precursors.

G A Currie, D W Hedley
PMCID: PMC2025452  PMID: 889676

Abstract

A micro-assay designed to assess the capacity of peripheral blood mononuclear cells to differentiate in vitro into mature macrophages is described. In patients with "final common pathway" malignant melanoma, there was a highly significant deficiency in macrophage precursors (MPs). By conventional morphological criteria such patients did not show a significant monocytopenia. Serum factors do not seem to contribute to the MP defect in the patients. We conclude that these patients have an intrinsic functional defect in their peripheral blood monocytes, but the mechanisms responsible for this defect are as yet unknown.

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Currie G. A., Basham C. Activated macrophages release a factor which lyses malignant cells but not normal cells. J Exp Med. 1975 Dec 1;142(6):1600–1605. doi: 10.1084/jem.142.6.1600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Currie G. A. Serum lysozyme as a marker of host resistance. II. Patients with malignant melanoma, hypernephroma or breast carcinoma. Br J Cancer. 1976 Jun;33(6):593–599. doi: 10.1038/bjc.1976.96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DIZON Q. S., SOUTHAM C. M. ABNORMAL CELLULAR RESPONSE TO SKIN ABRASION IN CANCER PATIENTS. Cancer. 1963 Oct;16:1288–1292. doi: 10.1002/1097-0142(196310)16:10<1288::aid-cncr2820161009>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  4. Eccles S. A., Alexander P. Sequestration of macrophages in growing tumours and its effect on the immunological capacity of the host. Br J Cancer. 1974 Jul;30(1):42–49. doi: 10.1038/bjc.1974.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Eccles S. A., Bandlow G., Alexander P. Monocytosis associated with the growth of transplanted syngeneic rat sarcomata differing in immunogenicity. Br J Cancer. 1976 Jul;34(1):20–27. doi: 10.1038/bjc.1976.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Evans R. Macrophages in syngeneic animal tumours. Transplantation. 1972 Oct;14(4):468–473. doi: 10.1097/00007890-197210000-00011. [DOI] [PubMed] [Google Scholar]
  7. Hibbs J. B., Jr, Lambert L. H., Jr, Remington J. S. Control of carcinogenesis: a possible role for the activated macrophage. Science. 1972 Sep 15;177(4053):998–1000. doi: 10.1126/science.177.4053.998. [DOI] [PubMed] [Google Scholar]
  8. Krikorian G., Marshall W. H., Simmons S., Stratton F. Counts and characteristics of macrophage precursors in human peripheral blood. Cell Immunol. 1975 Sep;19(1):22–31. doi: 10.1016/0008-8749(75)90288-9. [DOI] [PubMed] [Google Scholar]
  9. Rhodes J. Altered expression of human monocyte Fc receptors in malignant disease. Nature. 1977 Jan 20;265(5591):253–255. doi: 10.1038/265253a0. [DOI] [PubMed] [Google Scholar]
  10. SANFORD K. K., EARLE W. R., EVANS V. J., WALTZ H. K., SHANNON J. E. The measurement of proliferation in tissue cultures by enumeration of cell nuclei. J Natl Cancer Inst. 1951 Feb;11(4):773–795. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES